Granholm, Anders http://orcid.org/0000-0001-5799-7655
Alhazzani, Waleed
Derde, Lennie P. G.
Angus, Derek C.
Zampieri, Fernando G.
Hammond, Naomi E.
Sweeney, Rob Mac
Myatra, Sheila N.
Azoulay, Elie
Rowan, Kathryn
Young, Paul J.
Perner, Anders
Møller, Morten Hylander
Article History
Received: 30 September 2021
Accepted: 17 November 2021
First Online: 2 December 2021
Declarations
:
: The Department of Intensive Care at Copenhagen University Hospital—Rigshospitalet (AG, AP, MHM) has received grants from the Novo Nordisk Foundation, Pfizer, Fresenius Kabi and Sygeforsikringen “danmark” outside the submitted work. The University Medical Center Utrecht (LD) has received grants from the European Commission (Rapid European COVID-19 Emergency research Response (RECOVER) Grant number H2020 – 101003589; European Clinical Research Alliance on Infectious Diseases (ECRAID) Grant number H2020-965313) and the Dutch funder ZonMW (ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC)Grant Number 10150062010003) for REMAP-CAP. FGZ has received grants for investigator initiated clinical trials from Ionis Pharmaceuticals (USA) and Bactiguard (Sweden), all unrelated to this work. The Critical Care Division, The George Institute for Global Health (NEH) has received grants from Baxter, CSL, and Fresenius Kabi outside the submitted work. EA declares having received fees for lectures from Alexion, Sanofi, Baxter, and Pfizer. His institution has received research grants from Fisher&Payckle, MSD and Baxter.
Free to read: This content has been made available to all.